Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
BBVA $1 billion preferred securities offering
We advised BBVA on its offering of contingent convertible perpetual preferred securities
Minerva $100 million senior notes offering
The 8.875% senior notes are due 2033
JFE Holdings ¥119.5 billion stock offering
The offering of shares is concurrent with an offering of convertible bonds
Coty €500 million senior secured notes offering
The 5.75% senior secured notes are due 2028
JBS USA $2.5 billion senior notes offerings
The investment-grade notes are due 2034 and 2053
RayzeBio $358 million IPO
The stock is listed on the Nasdaq Global Market
Bank of America $8.5 billion floating- and fixed-to-floating-rate notes
The investment-grade debt offering is based on the Secured Overnight Financing Rate
Marvell Technology $1 billion senior notes offering
The senior notes are due 2029 and 2033
Mohawk Industries $600 million notes offering
The 5.85% senior notes are due 2028
SMFG $2 billion senior notes offering
We advised SMFG on its SEC-registered offering of TLAC notes